Results 1 to 10 of about 362,795 (239)

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients

Avicenna Journal of Medicine, 2023
Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease.
Atif Ibrahim, Asmi Chattaraj, Qamar Iqbal, Ali Anjum, Mohammad Ebad Ur Rehman, Zobia Aijaz, Fazila Nasir, Sadia Ansar, Tirdad T. Zangeneh, Ahmad Iftikhar   +9 more
doaj   +2 more sources

Pneumocystis Infection in Pregnant Women: A Scoping Review [PDF]

Journal of Fungi
Pneumocystis jirovecii is an opportunistic fungus that causes severe pneumonia in immunosuppressed individuals. While Pneumocystis colonization, a subclinical form of infection, has been studied in different populations, its implications during pregnancy
Irene Calderón-Baturone, Rocío Salsoso, Elena Charpentier, Yaxsier de Armas, Pilar Guadix, Rubén Morilla, Enrique J. Calderón, Vicente Friaza   +7 more
doaj   +2 more sources

Bone Marrow Infection by Pneumocystis jirovecii in a Patient with AIDS: A Case Report and Literature Review [PDF]

Infectious Disease Reports
Background: Pneumocystis jirovecii primarily causes pneumonia in immunosuppressed individuals, particularly those living with advanced HIV/AIDS. Extrapulmonary dissemination is uncommon, with bone marrow involvement described in only a handful of cases ...
Diego Alejandro Cubides-Diaz, Valentina Negrette-Lazaro, Viviana Poveda-Hurtado, Juan Pablo López-Salazar, Carlos Mauricio Calderón-Vargas, Carlos Arturo Álvarez-Moreno   +5 more
doaj   +2 more sources

Lung Injury in COVID-19 and Pneumocystis Pneumonia. Similarities and Differences

Туберкулез и болезни лёгких, 2022
In the regions with the high prevalence of HIV infection, it is necessary to perform differential diagnosis of lung injury caused by COVID-19 and pneumocystis pneumonia.The main complaints in COVID-19 and pneumocystis pneumonia are similar and include ...
E. A. Borodulina, E. S. Vdoushkina, E. V. Yakovleva   +2 more
doaj   +1 more source

The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia

Journal of Fungi, 2022
Pneumocystis jiroveci remains an important fungal pathogen in immunocompromised hosts. The environmental reservoir remains unknown. Pneumonia (PJP) results from airborne transmission, including in nosocomial clusters, or with reactivation after an ...
A. Apostolopoulou, J. Fishman
semanticscholar   +1 more source

Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments

Pathogens, 2021
For individuals who are immunocompromised, the opportunistic fungal pathogen Pneumocystis jirovecii is capable of causing life-threatening pneumonia as the causative agent of Pneumocystis pneumonia (PCP). PCP remains an acquired immunodeficiency disease (
Aaron D. Gingerich, K. Norris, J. Mousa
semanticscholar   +1 more source

Differences and similarities of high-resolution computed tomography features between pneumocystis pneumonia and cytomegalovirus pneumonia in AIDS patients

Infectious Diseases of Poverty, 2020
Background Accurately differentiating pneumocystis from cytomegalovirus pneumonia is crucial for correct therapy selection in AIDS patients. Hence, the goal of this study was to compare the computerized tomography (CT) features of pneumocystis pneumonia ...
Chun-Jing Du, Jing-Yuan Liu, Hui Chen, Shuo Yan, Lin Pu, Hao-Feng Xiong, Pan Xiang, Chuan-Sheng Li, Ming Zhang, Ru-Ming Xie, Bu-Dong Chen, Ang Li   +11 more
doaj   +1 more source

Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina

Pathogens, 2021
Pneumocystis jirovecii is a fungal pathogen that can cause life-threatening infections in individuals who are immunocompromised. Acquired via inhalation, upon entering the respiratory tract, the fungi first encounter innate immune cells such as alveolar ...
Theodore J. Kottom, Kyle Schaefbauer, Eva M. Carmona, Andrew H. Limper   +3 more
doaj   +1 more source

Case Report: Successful treatment of severe pneumocystis carinii pneumonia in a case series of primary nephrotic syndrome after receiving anti-CD20 monoclonal antibody therapy

Frontiers in Pediatrics, 2023
Rituximab is emerging as a new steroid sparing agent in children with difficult-to-treat nephrotic syndrome due to its ability of depleting CD20-positive B cells.
Lili Liu, Weihua Zheng, Ping Wang, Ying Wu, Guanghua Zhu, Rong Yang, Li Gu, Wenyan Huang, Yulin Kang   +8 more
doaj   +1 more source

Successful treatment of severe pneumonia in a diffuse large B-cell lymphoma patient after R-CHOP chemotherapy: A case report

SAGE Open Medical Case Reports, 2023
R-CHOP chemotherapy has been established as the first-line standard treatment for elderly patients diagnosed with diffuse large B-cell lymphoma. However, an increased risk of Pneumocystis jirovecii pneumonia in diffuse large B-cell lymphoma patients ...
Yan Xu, Zhaolin Li, Lamei Ouyang, Yinqing Su, Canmin Wang   +4 more
doaj   +1 more source